MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Quantitative demonstration of the efficacy of rotigotine transdermal patch in the treatment of nocturnal hypokinesia: A randomized, placebo-controlled trial using an axial inertial sensor

R. Bhidayasiri, J. Sringean, S. Chaiwong, C. Anan, K. Boonpang, K. Sakdisornchai, O. Jitkritsadakul, P. Jagota (Bangkok, Thailand)

Meeting: 2017 International Congress

Abstract Number: 1440

Keywords: Hypokinesia, Parkinsonism, Sleep disorders. See also Restless legs syndrome: Treatment

Session Information

Date: Thursday, June 8, 2017

Session Title: Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective: To evaluate the efficacy of rotigotine transdermal patch, using a wearable sensor, to treat PD patients with nocturnal immobility.

Background: Nocturnal hypokinesia is a common night-time symptom in Parkinson’s disease (PD), negatively affecting quality of life of both patient and caregiver. However, evidence-based treatment strategies are limited.

Methods: 34 PD subjects with nocturnal immobility were randomized to receive rotigotine transdermal patch (10.46+4.63 mg, 2-16 mg/24 hr, n=17) or placebo (n=17). Treatment was titrated to an optimal dose over 1-8 weeks, then maintain for 4 weeks. Primary endpoints were objective nocturnal parameters (number, velocity, acceleration, degree, and duration of turns and number of times patients got out of bed), measured using an axial inertial sensor (the NIGHT-Recorder) over two nights at the patients’ home. Correlations with validated clinical rating scales were performed. 

Results: There were significant improvements in the rotigotine group in terms of number of turns in bed (p=0.006), turning velocity (p=0.007), and the degree of turning (p=0.002). Significant improvements of mean total UPDRS, mean UPDRS-III, UPDRS-axial, PDSS-2, Nocturnal Akinesia Dystonia and Cramp scale and PDQ-8 were also observed. No significant changes were observed in the placebo group. The most frequently reported adverse events were feeling discomfort over the patch area (23%), application site reactions (5.8%), and itching (5.8%).

Conclusions: Our study demonstrates rotigotine transdermal patch provides a significant improvement, compared with placebo, on both objective nocturnal outcomes and clinical rating scales. It also demonstrates the feasibility of using wearable sensors to record objective outcomes in PD-related clinical trials.

References: 1) Bhidayasiri R., Sringean J., Thanawattano C. Sensor-based evaluation and treatment of nocturnal hypokinesia in Parkinson’s disease: An evidence-based review. Parkinsonism Relat Disord 2016;22 Suppl 1:S127-33.

2) Sringean J., Taechalerpaisarn P., Thanawattano C., Bhidayasiri R. How well do Parkinson’s disease patients turn in bed? Quantitative analysis of nocturnal hypokinesia using multisite wearable inertial sensors. Parkinsonism Relat Disord 2016;23:10-6.

To cite this abstract in AMA style:

R. Bhidayasiri, J. Sringean, S. Chaiwong, C. Anan, K. Boonpang, K. Sakdisornchai, O. Jitkritsadakul, P. Jagota. Quantitative demonstration of the efficacy of rotigotine transdermal patch in the treatment of nocturnal hypokinesia: A randomized, placebo-controlled trial using an axial inertial sensor [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/quantitative-demonstration-of-the-efficacy-of-rotigotine-transdermal-patch-in-the-treatment-of-nocturnal-hypokinesia-a-randomized-placebo-controlled-trial-using-an-axial-inertial-sensor/. Accessed May 18, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/quantitative-demonstration-of-the-efficacy-of-rotigotine-transdermal-patch-in-the-treatment-of-nocturnal-hypokinesia-a-randomized-placebo-controlled-trial-using-an-axial-inertial-sensor/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Effect of marijuana on Essential Tremor: A case report
  • Advanced Search
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley